News About: Pharm. Industry
Dong-A licenses Zydena to Meiji Seika
Dong-A Pharmaceutical Co. Monday announced the signing of an licensing-out agreement with Meiji Seika Pharma, granting Meiji exclusive rights to develop and commercialize Dong-A’s phosphodiesterase-5 inhibitor Zydena ...
CJ, VaxInnate to join forces in flu vaccine production
CJ CheilJedang Corp. announced Monday that it has signed an exclusive licensing agreement with the U.S. based VaxInnate Corporation, a privately-held biotechnology company, granting a license to CJ to manufacture, dev...
Korea drug firms urged to utilize exceptional clauses of patent linkage scheme
The country’s pharmaceutical companies face tough times ahead with the new Korea-U.S. Free Trade Agreement poised to strengthen patent rights for U.S. drug giants, heaping strain on the generic-focused Korean industry...
Laboratorios Cinfa to open Korean branch
Laboratorios Cinfa, S.A., a pharmaceutical company in Spain, plans to set up its Korean unit in the first half of next year, according to Lee Ju-chul, former marketing director of GlaxoSmothKline, who has been named a...
Hanmi signs deal to transfer platform technology to U.S. drug maker
Hanmi Pharmaceutical Co. signed Friday a $34 million deal with New York based Kinex Pharmaceuticals to transfer its ORASCOVERY, the platform technology that enables the development of orally available drugs.
Hanmi ...
Functional dyspepsia drug market getting heated
The domestic market of functional dyspepsia drugs is forecast to become more competitive than ever next year, with Dong-A Pharmaceutical that sees opportunities in the field where 20 leading drug makers have been stru...
Massive price cut plan will slash 13,000 jobs
A local university professor expressed concern about the country’s pharmaceutical industry.
In a local forum organized by Rep. Yang Sung-jo and the Federation of Korean Chemical Workers’ Union , Professor Kim Yang-...
Pfizer’s Apixaban gets nod from KFDA
Pfizer Korea said that the Korea Food and Drug Administration have approved its Eliquis (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
...
Multinational firms eager to recruit young recruits
It has become more difficult for young people to get a job as local pharmaceutical companies do not offer as many new positions as they used to in the past, amid the uncertain outlooks due to the government’s plan to ...
Large law firms eye large-scale lawsuit in pharmaceutical sector
Major law firms are setting their sights on the pharmaceutical sector, encouraged by drug makers’ collective suit against the Ministry of Health and Welfare to slash drug prices starting next April.
The Korea Pharm...
